- Secondary care >
- Pneumology >
- Lung cancer test kits
Lung cancer test kits
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Recommended for use in adults with an elevated risk for cancer, 40+ or older Lepu Medical has developed a methylated genes product for lung cancer detection. Only a tube of blood is needed for the non-invasive diagnostic tests Describe ...
Recommended for use in adults with an elevated risk for cancer, 40+ or older Detection of early colorectal cancer and precancerous lesions Patients with a positive test result should be referred for diagnostic colonoscopy. Patients ...
The Diagnostics kits of methylated genes of lung cancer are relied on a blood-based test and combine with proprietary epigenomics ctDNA methylation biomarkers for diagnosis of lung cancer, also known as abnormal gene epigenetic modification. ...
Intended use: Tianlong Human B-raf Gene V600E Mutation Detection Kit kit detects the genomic DNA extracted from paraffin-embedded tissue sections of human non-small cell lung cancer and colorectal cancer, and is used for the qualitative ...
Intended use: The Human K-ras Gene Mutation Detection Kit (PCR-Melting Curve Method) uses genomic DNA extracted from tumor paraffin-embedded tissue sections of human non-small cell lung cancer and colorectal cancer as test samples for ...
Result display time: 60 min - 90 min
Specificity: 97 % - 99 %
Sensitivity: 97 % - 99 %
This kit is used to in vitro qualitative detection of 14 types of ROS1 fusion gene mutations in human non-small cell lung cancer samples (Table 1). The test results are for clinical reference only and should not be used as the sole basis ...
Jiangsu Macro micro-test Medical Technology
This kit is used to qualitatively detect 12 mutation types of EML4-ALK fusion gene in samples of human nonsmall cell lung cancer patients in vitro (Table 1). The test results are for clinical reference only and should not be used as the ...
Jiangsu Macro micro-test Medical Technology
Result display time: 60 min - 90 min
Epidemiology Lung cancer has become the leading cause of cancer deaths worldwide, seriously threatening human health. Non-small cell lung cancer accounts for about 80% of lung cancer patients. EGFR is currently the most important molecular ...
Jiangsu Macro micro-test Medical Technology
"Selection of Patients Who Need Targeted Anti-Cancer Therapy" - Identification of NSCLC (Non-small Cell Lung Cancer) patients for EGFR Tyrosine Kinase Inhibitors (TKIs) treatment - Companion diagnostic test with Tarceva® (Erlotinib) ...
1. In non-small cell lung cancer, inv (2) (P21; P23) forms a molecular subunit of the fusion gene EML4-ALK, which is the target of the targeted drug Crizotinib. 2. A new EML4-ALK evaluation item was added to the 2010 non-small cell lung ...
Mutations in the epidermal growth factor receptor (EGFR) gene are predictive of the response to EGFR tyrosine kinase inhibitor (TKIs) therapies. The ViennaLab StripAssay® identifies 30 EGFR mutations relevant for non-small cell lung cancer ...
Result display time: 10 min
Specificity: 98 %
Sensitivity: 76 %
This Progastrin-Releasing Peptide(pro-GRP) POCT Kit is developed for the quantitative detection of Progastrin-Releasing Peptide in samples like human serum and plasma sample by self-developed LYOFIA® system. It's for in vitro diagnostic ...
EGFR (Epidermal Growth Factor Receptor), belongs to the proto-oncogene, On the short arm of human chromosome 7, containing 28 exons. EGFR mutations associated with TKI drug reactivity are concentrated in exon 18-21. There are 29 common ...
The HTG EdgeSeq ALKPlus Assay EU is an in vitro diagnostic (IVD), next-generation sequencing (NGS)-based assay intended to measure and analyze mRNA ALK gene fusion events in formalin-fixed, paraffin-embedded (FFPE) lung tumor specimens ...
The Accel-Amplicon Plus Lung Cancer Panel takes variant discovery and screening to a whole new level. It combines content from peer reviewed publications and other sources to offer comprehensive and exon-level hotspot coverage of 17 clinically-relevant ...
Lung cancer is categorized into two types; non-small cell lung cancer (NSCLC) with the 80~85% frequency and small cell lung cancer with the 15~20% frequency. Epidermal growth factor receptor (EGFR) is expressed on the surface of epidermal ...
Panagene Inc.
Result display time: 90 min
Stratagene Mx3000P Product description Adopting the ARMS-PCR method, this kit can be used to detect 9 EML4-ALK fusion genes, about mor than 90% of EML4-ALK fusion genes. This kit is used for qualitative assay of 9 EML4-ALK fusion ...
[Intended use] About 30% of various cancer patients harbor KRAS somatic mutations, such as 30-40% in colorectal cancer, 2-10% in non-small cell lung cancer and 90% in pancreatic cancer. In addition, 90% of all the mutations concentrate ...
Lung cancer is the most frequently diagnosed cancer and the leading cause of cancer mortality worldwide. Patients may suffer from one of two cancer types: Non-Small Cell Lung Cancer (NSCLC), or the less common, Small-Cell Lung Cancer ...
Your suggestions for improvement:
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining